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Lipoic acidRecent studies have revealed that mitochondria are able to synthesize fatty acids in a malonyl-CoA/acyl
carrier protein (ACP)-dependent manner. This pathway resembles bacterial fatty acid synthesis (FAS) type II,
which uses discrete, nuclearly encoded proteins. Experimental evidence, obtained mainly through using
yeast as a model system, indicates that this pathway is essential for mitochondrial respiratory function.
Curiously, the deﬁciency in mitochondrial FAS cannot be complemented by inclusion of fatty acids in the
culture medium or by products of the cytosolic FAS complex. Defects in mitochondrial FAS in yeast result in
the inability to grow on nonfermentable carbon sources, the loss of mitochondrial cytochromes a/a3 and b,
mitochondrial RNA processing defects, and loss of cellular lipoic acid. Eukaryotic FAS II generates octanoyl-
ACP, a substrate for mitochondrial lipoic acid synthase. Endogenous lipoic acid synthesis challenges the
hypothesis that lipoic acid can be provided as an exogenously supplied vitamin. Puriﬁed eukaryotic FAS II
enzymes are catalytically active in vitro using substrates with an acyl chain length of up to 16 carbon atoms.
However, with the exception of 3-hydroxymyristoyl-ACP, a component of respiratory complex I in higher
eukaryotes, the fate of long-chain fatty acids synthesized by the mitochondrial FAS pathway remains an
enigma. The linkage of FAS II genes to published animal models for human disease supports the hypothesis
that mitochondrial FAS dysfunction leads to the development of disorders in mammals.y, University of Oulu, PO Box
x: +358 8 5531141.
en).
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Recent research has brought to light many previously unknown or
underappreciated areas of physiology and biochemistry of mitochon-
dria. These observations include aspects of mitochondrial fusion and
ﬁssion events, linkage ofmitochondrial fusion events to the progression
of the cell cycle, mitochondrial–nuclear crosstalk, mitochondrial DNA
replication, transcription and translation, iron–sulfur cluster biogenesis,
and the role of mitochondria in apoptosis [1–5]. Among the recently
recognized features of mitochondrial functions is their ability to
synthesize fatty acids in an acyl carrier protein (ACP)-dependent
manner. The dual localization of fatty acid synthesis (FAS) in eukaryotic
cells raises the question of why eukaryotes have maintained FAS in the
mitochondria in addition to the “classic” cytoplasmic FAS (FAS I). The
mitochondrial FAS pathway is composed of a set of monofunctional
enzymes resembling the bacterial FAS II system and contrasts with the
eukaryotic cytosolic multifunctional complex.
Currently, most of our knowledge of mitochondrial FAS II (mtFAS II)
is based on data obtained from experiments with yeast. Yeast cellsdeﬁcient in mtFAS II have small mitochondria and a respiratory-
deﬁcient phenotype, lose spectrally detectable cytochromes, display
low lipoate content and have defects in mitochondrial RNA processing
(reviewed in Hiltunen et al. [6]). Apart from the role as a substrate in
lipoic acid synthesis, the fate of products of mtFAS II is still largely an
enigma (Table 1). All the enzymes that have been tested in vitro display
enzymatic activities with acyl substrates having chain lengths up to 16
carbon atoms. Generation of long-chain fatty acids can be demonstrated
also in labeling experiments with isolated mitochondria or their
extracts. Disruption of mitochondrial mtFAS II affects themitochondrial
phospholipid composition, but it is unclear whether this is an indirect
effect due to disturbed mitochondrial metabolism or a direct conse-
quence of reduced channeling of mitochondrially synthesized acyl
groups into phospholipids. Alternatively or additionally, mitochond-
rially synthesized long-chain fatty acids may be used for protein
acylation. A special example is 3-hydroxymyristoyl-ACP, which is a
component of mammalian mitochondrial complex I [7]. The best-
characterized physiological function of mtFAS II is to provide the
octanoyl chain for lipoic acid synthesis. Mitochondrial lipoic acid
synthesis seems to be an essential process in mammals; deletion of
lipoic acid synthase results in embryonic lethality in mice [8]. The
enzymology of mtFAS II has been reviewed recently [9], and thus, this
review emphasizes the biology and physiology of this mitochondrial
pathway.
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Most of the proteins of the mtFAS II pathway have been identiﬁed
using bioinformatic tools. Sequences of bacterial proteins were used
as probes to search for homologs, and subsequently, the activity of the
candidates was tested by functional complementation in vivo and/or
assaying recombinant proteins for enzyme activities in vitro. As
discussed below, however, three enzymes, 3-ketoacyl reductase
(KAR) in mammals, 3-hydroxyacyl thioester dehydratase 2 (HTD2)
in yeast and mammals, and the yeast 2-enoyl thioester reductase
(Etr1p) (Fig. 1), were not found by using this approach.
Whether as a part of multifunctional FAS I complexes or separate
entities of FAS II, all known KAR enzymes have similar sequences and
belong to the large superfamily of short-chain dehydrogenases/
reductases. Although the KAR enzymes share sequence similarity, two
mammalian homologs (provided with yeast mitochondrial targeting
sequences) onlyweakly complemented the yeast oar1Δmutation. Based
on the hypothesis that both gene productswere required simultaneously
to replace the missing function, the oar1Δ yeast cells were transformed
with both homologs on separate yeast expression plasmids. The result of
this experiment indicated that mammalian KAR is comprised of 17β-
hydroxysteroid dehydrogenase type 8 (17β-HSB8) and a carbonyl
reductase type 4 (CBR4). When the two components were expressed
together, they rescued the respiratory-deﬁcient phenotype and restored
the lipoic acid content of the oar1Δ yeast strain to wild-type levels.
17β-HSB8 and CBR4 form a mitochondrial complex, which can be
copuriﬁed as a heterotetrameric (α2β2) assembly when coexpressed inFig. 1. Mitochondrial fatty acid synthesis pathway. Schematic presentation of the
sequence of events. The indicated abbreviations follow the nomenclature used for the
human enzymes and proteins. ACC, acetyl-CoA carboxylase; MCT, malonyl-CoA
transferase; ACP, acyl-carrier protein; KAS, ketoacyl synthase; KAR, ketoacyl reductase;
HTD2, hydroxyacyl-thioester reductase type 2; ETR, enoyl-thioester reductase.Escherichia coli. The heterodimeric nature of human KAR is novel and
unexpected and explains its resistance to identiﬁcation via bioinfor-
matics. Most of the known KARs catalyze the reduction of 3-ketoacyl
thioesters in an NADPH-dependent manner, with the exception of the
mammalian enzyme [10] and the enzyme from Caenorhabditis elegans,
which are both NADH-dependent [11].
The FAS dehydratases from E. coli do not have clear homologs in
Saccharomyces cerevisiae, and an attempt to purify the enzyme from
yeast extracts failed. However, a genetic approach led to the
identiﬁcation of yeast mutants, which could be complemented by a
mitochondrially targeted chimeric bacterial hydroxyacyl-ACP dehydra-
tase encoded by fabA. In this screen, mutants were identiﬁed which
were unable to lose a plasmid carrying this construct when grown on
glycerol, a nonfermentable carbon source. YHR067w (later named
HTD2) was identiﬁed as the gene carrying the mutation [12]. The htd2
mutant yeast cells exhibited a respiratory-deﬁcient phenotype, loss of
mitochondrially encoded cytochromes, and a low level of lipoic acid,
similar to other mitochondrial FAS mutants. Surprisingly, no functional
mammalian homolog of yeast Htd2p could be found in the genome
databases. Screening of human cDNA libraries for clones that rescued
respiratory deﬁciency of the htd2Δ yeast strain identiﬁed several
candidates. Surprisingly, all of the rescued library plasmids harbored
RPP14 cDNA, previously described to encode the RPP14 subunit of
human RNase P.Whenwe further examined the cDNA, we found that it
carried two open reading frames on the same transcript. We were able
to demonstrate bygenetic andbiochemicalmeans that the open reading
frame 3′ of the previously characterized RPP14 sequence encoded
human 3-hydroxyacyl thioester dehydratase 2 (HTD2) [13]. Both the
fungal andmammalianmitochondrial FASdehydratases aremembers of
the MaoC dehydratase-like subfamily of thioester/thiol ester dehydra-
tase/isomerase (TED1) superfamily.
The last reaction of themtFAS II cycle is catalyzed by Etr1-type enoyl
thioester reductases. The ﬁrst eukaryotic Etr1 was identiﬁed by
purifying and subsequently cloning the gene for an enzyme capable of
reducing double bonds in 2,4-hexedienoyl-CoA in an NADPH-depen-
dentmanner fromCandida tropicalis [14]. Thisproteinwas shown tobea
2-enoyl-CoA/ACP reductase ofmtFAS II, and because it accepts both CoA
and ACP thioesters as substrates, it was named enoyl thioester
reductase. The enzymes involved in fatty acid synthesis in various
subcellular compartments and organisms comprise a fascinating
example of functional convergence during evolution. Namely, most of
the prokaryotic enzymes are short-chain alcohol dehydrogenase
proteins. In contrast, eukaryotic mitochondrial Etr1s (the enoyl
reductases of the fatty acid chain elongation system in the endoplasmic
reticulum and the corresponding catalytic domain in the mammalian
cytosolic FAS complex) are medium chain alcohol reductase/dehydro-
genases [14–16]. Curiously, the enoyl reductase domain of yeast
cytosolic FAS and bacterial FabK both have a TIM-barrel fold [16].
3. Lipoic acid and protein lipoylation
Although almost 60 years have passed since the ﬁrst identiﬁcation of
lipoic acid (thioctic acid, thiotic acid, 6,8 dithiooctanoic acid) [17], the
enzymatic steps that lead to the synthesis of lipoic acid (LA) and protein
lipoylation in E. coli have been characterized in detail only recently
[18–23]. Several aspects of the generation of this important mitochon-
drial enzyme cofactor are still not well understood. Moreover, the
investigation of eukaryotic LA synthesis has begun only recently.
LA acts as a “swinging arm” domain in keto acid dehydrogenases,
whichare enzymecomplexes that carryout theoxidativedecarboxylation
of 2-keto-acids [24]. Typically, these complexes are composed of
oligomeric superstructures of three subunits, a decarboxylase (E1,
mono/dimeric), a dihydrolipoyltransferase (E2), and the dihydrolipoyl
dehydrogenase (E3). Yeast has two of these enzyme complexes, α-
ketoglutarate dehydrogenase (KDH) andpyruvate dehydrogenase (PDH),
while higher eukaryotes also harbor a mitochondrial branched chain α-
Table 2
Lipoic acid synthesis and transfer enzymes.
Function/Organism Gene Reference
Lipoic acid synthase
E. coli lipA [27]
S. cerevisiae LIP5 [34]
Mammalian Lias (mouse), LIAS (human) [36,50]
Lipoyl-(octanoyl)-protein ligase
E. coli lipB [82]
S. cerevisiae LIP2 [37]
Mammalian LIPT2 [83,84]
Lipoyl-(octanoyl)-protein ligase
E. coli lplA [30,31]
S. cerevisiae LIP3 [35]
Mammalian LIPT1 [38,39]
Lipoate-activating enzyme
Mammalian ACSM1 [40]
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(protein X, Pdx1p in yeast) homologous to E2, which is required for
binding of E3 to E2 in yeast (Table 1) [25]. An additional lipoylation-
dependent complex is the glycine cleavage system/glycine decarboxylase
(GC) [26]. This multiprotein complex comprises a decarboxylase (P), a
dihydrolipoyl dehydrogenase (L) identical to the E3 subunits, tetrahy-
drofolate dehydrogenase (T), and the loosely associated LA-bearing H
protein.While not quite as highly similar to the keto-aciddehydrogenases
as they are to each other, GC is also related to these enzymes. All these
complexes aremitochondrial in eukaryotes, and in all cases, LA is attached
via an amide bond to the N6 amino group of a conserved lysine residue in
the E2 subunit or the analogous H protein of GC.
4. Lipoic acid synthesis
LAmetabolismhas been investigatedmost thoroughly in E. coli. In this
modelorganism,denovo synthesis of the cofactor starts fromoctanoic acid
moieties producedby thebacterial FAS II pathway. Experimental evidence
supports amodel of transfer of octanoic acid fromoctanoyl-ACP by lipoyl-
(octanoyl)-protein ligase (LipB) to the target proteins before sulfur
insertion by lipoic acid synthase (LipA) [19], an enzymewith similarity to
biotin synthase [27]. The sulfur insertion by the dual iron–sulfur cluster
enzyme LipA requires two molecules of S-adenosyl-L-methionine per
molecule of LA produced [28,29].
E. coli can also utilize lipoic or octanoic acid supplied exogenously
in anATP-dependent transfer route catalyzedby the lipoyl-(octanoyl-)
protein ligase (LplA) [30,31]. The transfer process occurs in two
distinct steps. In the ﬁrst reaction, LA is activated to lipoyl-AMP, while
the second reaction results in the transfer of LA to the recipient protein
[30]. An intriguing question is whether LA is available in its free form
under physiological conditions. E. coli apparently lacks an enzymewith
lipoamidase function that is required for release of the cofactor from
lipoylated oligopeptides or proteins [32]. Most LA is found bound to
proteins via a stable amide linkage and is released only by harsh
treatment (prolonged acid hydrolysis under pressure and high
temperature), conditions not available in the mammalian gut. It has
been reported, however, that cell sap from plant leaves contains a low
but measurable amount of free LA [33].
In eukaryotes, several homologs of the E. coli enzymes have been
identiﬁed (Table 2). Eukaryotic lipoic acid synthase was ﬁrst identiﬁed
in yeast. The gene was cloned by complementation of a mutation
causing respiratory deﬁciency as well as, curiously, a mitochondrial
tRNA processing defect [34]. Further analysis of the mutant strain
demonstrated that a mutation in the LIP5 gene, encoding a proteinwith
high similarity to E. coli LipA,was responsible for the phenotype. Growth
of the lip5 mutant on media supplemented with LA did not rescue
respiratory deﬁciency. It was shown later that lipoylated proteins
cannot be detected in a lip5Δ yeast strain [35]. Amouse homolog of LIP5
and lipA was identiﬁed in 2001 [36]. Inactivation of the mouse gene
(Lias) led to embryonic lethality, and this phenotype could not be
rescuedby administration of LA to themothers [8]. From these studies, it
is clear that lipoic acid must be synthesized intramitochondrially to
support normal growth and development.Table 1
Conﬁrmed and proposed products and functions of mtFAS II.
Product Function
Lipoic acid Cofactor for pyruvate dehydrogenase,
α-ketoglutarate dehydrogenase,
the branched chain α-keto acid
dehydrogenase and glycine cleavage c
3-Hydroxymyristoyl-ACP Component of complex I
Long-chain fatty acids aPhospholipid remodeling
aProtein acylation/membrane anchor
a Suggested.Yeast lipoyl-(octanoyl)-protein ligase (Lip2p) [37] is required for
respiration and is sufﬁcient for the transfer of octanoic acid/LA to
Gcv3p, the H protein of GC (Fig. 2). It is also necessary for the
lipoylation of the E2 subunits of KDH and PDH but is unable to support
the modiﬁcation of the latter two proteins in the absence of Lip3p, the
yeast homolog of bacterial LplA [35] (see below). To date, mammalian
homologs of Lip2p/LipB have been identiﬁed but not characterized.
Human lipoyltransferase, LIPT1, shares 31% identity with E. coli LplA
[38]. However, like the bovine homolog [39], LIPT1 lacks the ability to
activate LA. It has been shown that in cows, this ﬁrst step required for
attachment of free LA to proteins may be carried out by a separate
protein called lipoate-activating enzyme (ACSM1 = acyl-CoA synthe-
tase medium chain family member 1), which requires GTP instead of
ATP to form lipoyl-GMP [40]. However, as the gene name suggests, this
protein also has high medium chain acyl-CoA synthetase activity and
may also play a role in mitochondrial β-oxidation [41]. The yeast
homolog encoded by theORFYJL046wwas initially identiﬁed in a screen
for mutants deﬁcient in mitochondrial RNA processing [35]. Sequence
analysis indicated similarity to lipoyl transferases, and subsequent tests
indicated that the yjl064wΔ strain was unable to complement the
previously described LA-deﬁcient lip3mutation reported in a collection
of respiratory-deﬁcient yeast strains [42], and consequently, the gene
was termed LIP3 [35]. It was demonstrated by Western blot analysis
using anti-LA antiserum that LIP3 was necessary but not sufﬁcient for
the lipoylation of the Lat1p and Kgd2p E2 subunits of PDH and KDH,
respectively. Intriguingly, however, despite very low cellular LA levels,
the Gcv3p H protein was lipoylated in the lip3Δ mutant. Moreover,
deletion of GCV3, but not of the other components of GC, completely
abolished protein lipoylation in yeast [35]. It was postulated from these
results that Lip2p, Lip3p, Lip5p, and Gcv3p may form a lipoylation
complex. The E3/L protein, Lpd1p, also may be required for efﬁcient
lipoylation, as deletion of the LPD1 gene results in a reduction of
lipoylated proteins in yeast cells. In a “Faculty of 1000” comment on thisModel system Reference
omplexes
Pea leaves [75]
Yeast [57,76]
Bovine heart [77]
Bovine heart [7]
Yeast [78]
T. brucei [79]
Yeast [80,81]
Fig. 2.Model proposed for lipoic acid synthesis and attachment in yeast. According to the model, Lip2 transfers an octanoyl group from ACP to Gcv3p (the H-protein) of the glycine
cleavage system followed by lipoic acid synthesis in the reaction catalyzed by Lip5p. Lipoylated Gcv3p acts as a substrate intermediate for lipoylation of other mitochondrial target
proteins in a Lip3p-dependent manner. The question mark indicates that the details of this process are unknown. For details, see text. SAM, S-adenosyl-L-methionine.
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a lipoylation intermediate acting as a substrate for Lat1p and Kgd2p
lipoylation (Fig.2). While this is a tempting speculation, it has to be
pointed out that the data available thus far are not sufﬁcient to draw this
conclusion, as direct transfer of LA fromGcv3p to Lat1p or Kgd2p remains
to be demonstrated. It also requires the postulation of a novel
lipoamidase transferase activity, which has not been described to date.
An alternative mechanism with two or three separate activities for
cleavage of LA from Gcv3p, activation of LA and transfer to the other
targets appears unnecessarily complicated, but cannot be ruled out. Can
Lip3p transfer LAdirectly fromGcv3p to theE2proteins ofKDHandPDH?
Howwould this be achieved on themolecular level? Itwill be interesting
also to determine if lipoylation in humans follows a similar route. It is not
clearwhy lipoylation of Gcv3p in yeastmitochondria is a prerequisite for
lipoylation of the other enzymes. A Gcv3p intermediate certainly adds an
extra layer of control to the lipoylation process, possibly coordinating
mitochondrial one-carbon metabolism with respiration.
The only lipoamidase characterized thus far is Lpa of Enterococcus
faecalis, an organism unable to synthesize LA and condemned to
scavenging LA from its environment [32]. Lipoamidase activities have
been reported to have been isolated from pig brain [43] and other
mammalian sources as well as yeast [44], but the existence of these
enzymes is controversial [32], and an additional transferase activity has
not been reported. However, it was demonstrated in ACP knockdown
experiments inHEK293cell culture that levels of LA-modiﬁedproteins are
undetectable with the LA-speciﬁc antiserum, but the levels of the
unmodiﬁed proteins are unchanged. Hence, LA appears to be turned
over more rapidly than the proteins in mammalian cells, implying the
existence of an activity for removal of this moiety [45].
5. Endogenously synthesized versus alimentary-acquired
lipoic acid
The discovery of the mammalian mtFAS II pathway and lipoic acid
synthase challenges the hypothesis that lipoic acid is a vitamin that canbe supplied exogenously. While there have been many studies on
uptake andmetabolism of free LA from industrially synthesized sources
(e.g., [46–48]), to our knowledge there is no comprehensive investiga-
tion on the bioavailability of LA from natural foodstuffs, and the fate of
externally supplied LA in mammals has not been properly addressed.
Likewise, while it is obvious that the main features of LA resulting in
beneﬁcial effects are its role as an antioxidant and as an inducer of
endogenous antioxidants [48], it is not clear if dietary-supplied LA is
utilized as a cofactor in mitochondrial enzymes complexes. In yeast, LA
added to the growthmediumdoes not rescue the respiratory deﬁciency
of a lip5 lipoic acid synthasemutant [34]. It is stated in this work that LA
could be recovered in protein-bound form, but it was not shown to
which proteins and by what linkage LA was attached. It was also
concluded by others that exogenously supplied LA is either not taken up
into yeastmitochondria or not activated [49], and our own unpublished
work supports this conclusion. The embryonic lethality of the mouse
Liasknockoutmutantwasnot rescuedby additionof LA to the diet of the
mother [8], and supplementation of ACP knockdownHEK293 cells with
LA also had no effect on the lipoylation phenotype of these cells,
indicating that exogenously supplied LAmay not be available also to the
mammalian mitochondrial enzymes [45]. On the other hand, a
beneﬁcial effect of lipoic acid on lipoic acid synthase knockdown in
cell culture was reported [50]. Also, addition of LA to ﬁbroblasts from a
patient with multiple deﬁciencies in LA-dependent enzyme activities
apparently improved BCD function [51], but it was not shown if this
effect was caused by incorporation of the cofactor into BCD, or a general
improvement of mitochondrial function due to the antioxidant
properties of LA. It is remarkable, however, that the latter publication
may actually describe a patient suffering from a genuine LAmetabolism
or mtFAS II deﬁciency. Interestingly, another group of patients
displaying a similar syndrome affecting multiple mitochondrial func-
tions was described more recently [52]. Although the PDH E1 subunit
activity defect of these patients may indicate a thiamine deﬁciency
rather thanmtFAS II or LA synthesis lesions, patients with defects in the
latter two linked pathways may display a similar pattern of symptoms.
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Both human and yeast mitochondrial genomes are transcribed
into multigenic precursor RNAs that must be processed to produce
mature messenger, transfer, and ribosomal RNAs. The major
precursor RNA produced in mitochondria of most eukaryotes and
many fungi is almost of genome-length; themajority of the genes are
coded for on one strand of the DNA (reviewed in Falkenberg et al.
[53]). mRNAs and rRNAs are interdigitated with tRNAs [54] and thus
are freed from the precursor by the enzymes that process the 5′ and
3′ ends of tRNAs, RNase P, and an unidentiﬁed 3′ tRNA endonuclease,
respectively. The S. cerevisiae mitochondrial genome is expanded in
size by large regions of noncoding AT-rich sequences and introns, and
several major precursor RNAs contain combinations of mRNAs,
rRNAs and tRNAs (reviewed in Dieckmann and Staples [55]). The
presence of introns and the uneven distribution of tRNAs are such
that processing of the precursors to functional mature RNAs requires
more than just the tRNA processing enzymes (reviewed in Schafer
[56]).
In the pursuit of unidentiﬁed RNA processing enzymes in yeast
mitochondria, we undertook a screen of the haploid yeast gene
knockout collection for uncharacterized genes defective in the
processing of complex precursor RNAs. Two deletion mutants were
identiﬁed that had a retarded rate of processing of the precursor
RNA containing both the prolyl tRNA and the RNase P RNA. Quite
surprisingly, the mutant with the most severe phenotype had a
deletion in a gene coding for an enzyme of the fatty acid
biosynthetic pathway exclusive to the organelle, mtFAS II.Fig. 3. Intersection of the mtFAS II-LAS pathway and RNase P activity in yeast mitochondria
(lipoic acid synthesis) pathway convert octanoic acid to lipoic acid and attach the cofactor to
andα-KDH enzymatic activity. The dotted arrow represents the requirement of a product of
is transcribed in a single transcription unit with downstream tRNApro. RNase P processes
intermediate. Further processing at the 5′ end of this intermediate in a Pet127-dependent rea
activity are shown. (B) A Northern blot of total RNA extracted from wild-type and htd2Δ str
SCR1, the RNA subunit of the cytoplasmic signal recognition particle, was used as a loadingSubsequently, it was found that deletions of any of the genes
coding for the mtFAS II enzymes resulted in a similar phenotype
[57]. The other mutant discovered in the screen had a less severe
backup of precursor RNA and was missing the yeast homolog of an
enzyme in the salvage pathway for lipoic acid attachment in E. coli
[35].
As shown in Fig. 3, the processing event that is retarded in the
mutant strains is an RNase P cleavage at the 5′ end of tRNApro. It is
curious that the activity of RNase P is required for processing the
precursor RNA that contains the RNase P RNA (RPM1). The RNA
assembles with a protein, Rpm2p, which is encoded in the nucleus,
translated in the cytoplasm, and imported into the organelle [58]. The
requirement of RNase P activity for the maturation of its own RPM1
RNA subunit creates a positive feedback loop that may make the
induction/turndown of mitochondrial function more switch-like in
response to nutritional or other cues [59].
Since lipoic acid is a key synthetic product of the mtFAS II–LAS
pathway, it was attractive to hypothesize that Rpm2p might be
modiﬁed by lipoic acid. However, we cannot detect lipoic acid
modiﬁcation of Rpm2p using an antibody against lipoic acid [57],
which detects the cofactor cleanly on the abundant E2 subunits of
PDH and α-KDH, and the H protein of GC. Moreover, since the RNA
processing defect of the mtFAS II mutants is more severe than that
of any one of the LAS mutants or combinations thereof, our current
hypothesis is that a product of the mtFAS II pathway, octanoic acid
or a longer fatty acid, may modify Rpm2p covalently, or affect
RNase P activity by noncovalent association, or affect its activity
indirectly.. (A) The major product of the mtFAS II pathway is octanoyl-ACP. Enzymes in the LAS
target proteins. The dashed arrows represent the requirement of lipoic acid for GC, PDH
mtFAS II or LAS for efﬁcient processing of RPM1-containing transcripts by RNase P. RPM1
the pre-RPM1-pro precursor RNA at the 5′ end of tRNApro, generating the pre-RPM1
ction produces mature RPM1 RNA. Positive feedback loops for PDH activity and RNase P
ains was hybridized with a probe complementary to RPM1. A probe complementary to
control.
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The mammalian mitochondrial genome exists as a closed circular
molecule, with a size of 16,569 bp in humans [60] and approximately
16,300 bp in mouse [61]; thus, it is relatively small compared to yeast
mitochondrial DNA. It codes for 13 polypeptides needed for oxidative
phosphorylation, as well as 2 ribosomal RNAs and 22 transfer RNAs for
protein translation. The transcription of either strand produces polycis-
tronic precursor RNA molecules, which are then further processed to
separate mRNAs, tRNAs, and rRNAs. Similar to yeast, genes encoding
proteins and rRNAs are bordered by at least one tRNA gene [60], and thus,
processing of 5′ ends of tRNAs by RNaseP and 3′ ends by an
uncharacterized enzyme leads to separation of all the other RNAs [62].
Nuclear RNase P is responsible for the 5′ processing of all nuclear
tRNA precursors before export to the cytoplasm. The yeast enzyme
comprises many protein subunits and a nuclearly encoded catalytic
RNA. RPP14, one of the nuclear RNase P protein subunits, is translated
from a highly conserved bicistronic mRNA, which also encodes mtFAS
II dehydratase Htd2p [13]. The rare bicistronic nature of this mRNA
hints at a possible link between mtFAS II and RNA processing in
vertebrates.
Mitochondrial tRNAs are transcribed as part of larger precursor
transcripts and also require 5′ processing by an RNase P activity. It has
been thought that the nuclear enzyme is imported into the organelle
because it was puriﬁed from isolated HeLa cell mitochondria [63].
Also, there is no RNase P RNA encoded in the human mitochondrial
genome that would hint at a separate enzyme assembled in the
organelle. However, recently, a mitochondrial RNase P containing no
RNA subunit, or any protein subunits common to the nuclear enzyme,
was puriﬁed from HeLa cell mitochondria [64].
HumanMRP nuclease, which is required for rRNA processing in the
nucleolus [65,66], shares many protein subunits with the nuclear
RNase P [67,68], although RPP14 may be underrepresented in this
enzyme. MRP nuclease has been reported to be localized in
mitochondria also [69], where it cleaves the RNA primers required
for mitochondrial DNA replication [70]. Why the RPP14 nuclease
subunit and HTD2 dehydratase are expressed from the same mRNA
remains a mystery.8. mtFAS II and mitochondrial morphology
One aspect of mtFAS II that has remained largely neglected is the
effect of loss-of-function mutations or overexpression of mtFAS II
components on mitochondrial morphology. Mitochondria of yeast
cells lacking functional mtFAS II appear small and rudimentary under
the electron microscope and exhibit a fragile, more highly branched
morphology than mitochondria of wild type cells when examined by
ﬂuorescence microscopy [12,14,57]. While it may not be surprising
that the nonfunctional organelle also exhibited changes in physical
appearance, the phenotype of overexpression mutants is less
intuitive. During our studies of yeast Etr1p localization, we observed
a remarkable enlargement of the mitochondrial compartment [14]
upon overexpression of either the wild-type S. cerevisiae or the C.
tropicalis protein under transcriptional control of the S. cerevisiae CTA1
catalase promoter. This effect was also observed, albeit to a lesser
extent, upon overexpression of mitochondrially localized E. coli FabI,
the homolog of Etr1p, indicating that the phenomenon is likely due to
increased enoyl reductase activity. Likewise, overexpression of Htd2
dehydratase resulted in enlargedmitochondria, but the effect was less
dramatic [12]. As observed by electron microscopy, the enlarged
organelles appeared to lack or only possess rudimentary cristae
structures [12,14]. Recently, we have reported a similar mitochondrial
morphology phenotype when the Mecr homolog was overexpressed
in mice [71], indicating a possible conservation of function in
maintenance or modulation of mitochondrial shape and appearance.Thus far, there is no explanation on a molecular level for these
observations.
9. A regulatory role for mtFAS II in the mitochondrial response to
pyruvate/acetyl-CoA?
One of themajor sources of mitochondrial carbon input is in the form
of pyruvate produced by glycolysis. Pyruvate enters the organelle and is
converted to acetyl-CoA by the immense pyruvate dehydrogenase
complex [72]. The activity of this enzyme requires the swinging arm
lipoic acid cofactor to carry the reaction intermediates between the three
distinct active sites of the enzyme andparticipate in the reactions.Most of
the acetyl-CoA produced by the enzyme ﬂows into the tricarboxylic acid
cycle to produce reducing equivalents for the electron transfer chain.
However, some of the acetyl-CoA is the substrate for the mtFAS II
pathway. Similar to the positive feedback cycle in mitochondrial RNase P
production and activity, there is an additional positive feedback cycle in
pyruvate dehydrogenase activity and LA synthesis/attachment in the
organelle (Fig. 3). Furthermore, these two positive feedback cycles are
linkedby theneed foranmtFAS II product tooptimizeRNasePactivity. It is
tempting to speculate that these cycles exist to regulate mitochondrial
function in response to nutritional input.
10. mtFAS II and disease
As previouslymentioned in this review, there exist reports of patients
with syndromes consistent with a defect in mtFAS II or LA synthesis
[51,52] and of cell death in cultured human embryonic kidney 293T cells
upon shutdown of ACP using RNAi technology, which compromises
protein lipoylation and respiratory complex I activity [45]. There is also
other emerging evidence that links the mtFAS II pathway to disease in
mammals. Our recent report on the development of cardiomyopathy in
mice overexpressing Etr1p established a possible connection between
mtFAS II and heart disease (Fig. 3) [71]. Furthermore, decreased
expression of 17βHSD8, a subunit of KAR1 [10], has been associated
with disease. 17βHSD8 is localized in the leukocyte antigen centromeric
region of chromosome 6, which is a critical disease-susceptibility region
affectingmultiplepathways [73]. Theexpressionof17βHSD8was severely
repressed in kidney and liver of polycystic kidney disease mouse models
tested thus far [74]. As we learnmore about the mitochondrial FAS II and
LAS pathways, additional human diseases and syndromes may be linked
to deﬁciencies of the enzymes in these pathways.
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The abbreviations for lipoic acid synthesis attachment pathways in different species are
summarized in the Table 2.
17βHSD: 17β-hydroxysteroid dehydrogenase
ACP: acyl carrier protein
BCD: branched-chain keto-acid dehydrogenase
E1, E2, and E3: a decarboxylase, dihydrolipoyltransferase, and dihydrolipoyl
dehydrogenase subunits in keto-acid dehydrogenase enzyme complexes, respectively
ETR: enoyl thioester reductase
FAS: fatty acid synthesis
GC: glycine cleavage
Gcv3p: the H-protein of glycine cleavage system
HTD: 3-hydroxyacyl thioester dehydratase
KAR: 3-ketoacyl reductase
KDH: α-ketoglutarate dehydrogenase
LA: lipoic acid
Lat1p: dihydrolipoyltransferase (E2) in yeast
mtFAS: mitochondrial FAS
PDH: pyruvate dehydrogenase
